ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology
about
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonistsGlutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system.'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice.A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.Anticoagulation intensity of rivaroxaban for stroke patients at a special low dosage in JapanPatterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with theAspirin use and risk of atrial fibrillation in the Physicians' Health Study.Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcareTroponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart reviewGenetics of atrial fibrillation and possible implications for ischemic stroke.Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation.Matrine inhibits pacing induced atrial fibrillation by modulating I(KM3) and I(Ca-L).Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry.Atrial Fibrillation Is an Independent Risk Factor for Hospital-Acquired Pneumonia.Could successful cryoballoon ablation of paroxysmal atrial fibrillation prevent progressive left atrial remodeling?Clopidogrel versus Other Antiplatelet Agents for Secondary Prevention of Vascular Events in Adults with Acute Coronary Syndrome or Peripheral Vascular Disease: Clinical and Cost-Effectiveness Analyses.Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population.Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trialPharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome.Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link.Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor.Atrial fibrillation in end-stage renal disease.Atrial fibrillation among the black population in a Ugandan tertiary hospitalThe Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.The role of the renin-angiotensin system blocking in the management of atrial fibrillation.Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke.Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialAngiotensin II receptor blockers in the prevention of complications from atrial fibrillationRivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme.Management of patients with risk factors.
P2860
Q24647947-5DB3E37F-3FD6-45B9-B9AC-2B141A554CC1Q33421711-E7DF897C-7599-4EA4-A4C0-27571DB0DC77Q33541615-5E544679-361B-4650-84AE-6EF3552301A6Q33585592-99D2BCDE-00AC-4AD0-A4C2-E4294D28B796Q33931999-6271F217-6F0E-4EE7-BDD7-421014B30BF4Q34135274-AD8FB306-F1C6-46FA-8AB9-AE7FB58CBB64Q34175991-1D4A0D4F-BF8C-4486-A14D-AE31606FEFDFQ34187660-E63F83E5-6E80-499D-B145-60F4BBB85D26Q34307919-A7CFFA16-6CCC-4CF3-BBCD-20EB90F5B559Q34525542-6F18EBC8-73EE-4756-AFFA-49CCD0B79088Q34609020-DED4EEE6-6864-4C60-93A4-7BEF4BAC8C46Q34642367-9F227CB7-EAAF-44CB-B7B6-E34B2884C188Q34712397-69456CBE-1FA8-48DE-8BF7-2B0054EB1BAFQ34737465-D7587360-59DF-4A1A-B078-84FDA824C47BQ34830023-51905B7F-6435-4F92-8407-4FC1101A137DQ35026193-B5954FEF-C231-4721-85F6-21DB23EE4E4AQ35063716-36ECF941-7FBB-49C1-B4FB-4DD07DF809CBQ35078081-31EF24D8-B0B5-449E-A53D-FF10B83BE87EQ35142380-88FFAFC6-8455-47E3-B43C-99FA9F8785FBQ35287322-8B754EBE-749A-4340-99DC-6B410A82A031Q35641994-E502D13F-C37C-479C-9B50-31730F28E6F3Q35660429-BA3D230E-1BEE-4DC5-A069-74CA00FBA9B7Q35882737-CFEA559B-6388-40E4-B4DD-770249E58AD3Q35998538-FA14029A-7865-43AA-8262-2DDCC98A6EFDQ36234962-0FA1B8B7-F44B-4F41-A3C2-633B45A84E68Q36472678-211DCFD3-8720-42BC-814F-17478F8950E1Q36527221-222028EA-5B5A-402F-9EBD-484614938D00Q36632222-165DF4A5-279C-4665-980B-7E454F692A44Q36811824-5C528DFC-CEBD-48DF-A7AA-BA234F56B71AQ36848629-CD14AD77-F4C5-4616-ABE2-6FEB721B5B03Q36988001-5C0DC60B-028C-4BA5-B214-5B4D97EE8F46Q36988390-B5476F01-488D-44F4-BA80-34D78C236138Q37007282-5D84B547-BD47-4AAD-9FB9-FB54D1AEC6AAQ37137707-878FCA63-7885-4AAE-B6BD-5D0E2964C313Q37166906-713EAA82-004B-4687-A101-89241F7F1C64Q37250616-BD4B6E19-412E-4D11-ABC6-41CB9A182C86Q37285957-F223FFAF-90B3-45FB-9A4A-7C583F6874C5Q37354665-3CF6F27A-C0CF-4EA8-AD9C-35D8256D04A6Q37383508-AC240930-838C-45C0-9047-73151CC557F5Q37448133-0C6D13E6-0C9B-4372-A8BB-2BEA1A249D19
P2860
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@en
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@nl
type
label
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@en
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@nl
prefLabel
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@en
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@nl
P2093
P50
P356
P1476
ACC/AHA/ESC 2006 guidelines fo ...... European Society of Cardiology
@en
P2093
Anne B Curtis
Committee for Practice Guidelines, European Society of Cardiology
David S Cannom
Eric N Prystowsky
G Neal Kay
Harry J Crijns
James E Lowe
Jean-Yves Le Heuzey
Lars E Rydén
S Bertil Olsson
P304
P356
10.1093/EURHEARTJ/EHL176
P50
P577
2006-08-01T00:00:00Z